Publicaciones (28) Publicaciones en las que ha participado algún/a investigador/a

2015

  1. A novel performing PEG-cholane nanoformulation for Amphotericin B delivery

    International Journal of Pharmaceutics, Vol. 495, Núm. 1, pp. 41-51

  2. Agitation Rate and Time for Complete Dissolution in BCS Biowaivers Based on Investigation of a BCS Biowaiver for Dexketoprofen Tablets

    Molecular Pharmaceutics, Vol. 12, Núm. 9, pp. 3194-3201

  3. Analysis of drugs of abuse in human plasma by dispersive liquid-liquid microextraction and high-performance liquid chromatography

    Journal of Applied Toxicology, Vol. 35, Núm. 4, pp. 418-425

  4. Chitosan and Kappa-Carrageenan Vaginal Acyclovir Formulations for Prevention of Genital Herpes. In Vitro and Ex Vivo Evaluation

    Marine Drugs, Vol. 13, Núm. 9, pp. 5976-5992

  5. Critical attributes of formulation and of elaboration process of PLGA-protein microparticles

    International Journal of Pharmaceutics, Vol. 480, Núm. 1-2, pp. 27-36

  6. Ebulin from dwarf elder (Sambucus ebulus L.): A mini-review

    Toxins, Vol. 7, Núm. 3, pp. 648-658

  7. Efficacy and toxicity evaluation of new amphotericin B micelle systems for brain fungal infections

    International Journal of Pharmaceutics, Vol. 494, Núm. 1, pp. 17-22

  8. Elderberries: A source of ribosome-inactivating proteins with lectin activity

    Molecules, Vol. 20, Núm. 2, pp. 2364-2387

  9. Emerging nanonisation technologies: Tailoring crystalline versus amorphous nanomaterials

    Current Topics in Medicinal Chemistry, Vol. 15, Núm. 22, pp. 2327-2340

  10. Enmascaramiento de sabores en formas farmacéuticas sólidas orales

    Anales de la Real Academia Nacional de Farmacia, Núm. 2, pp. 116-128

  11. Enmascaramiento de sabores en formas farmacéuticas sólidas orales

    Anales de la Real Academia Nacional de Farmacia, Vol. 81, Núm. 2, pp. 116-128

  12. Entrevista a los ponentes del Encuentro Filosofía-Farmacia: Pensando el presente: la farmacia moderna

    Tales: Revista de la Asociación de Alumnos de Postgrado de Filosofía, Núm. 5, pp. 337-342

  13. HPLC-UV method development and validation for the quantification of ropinirole in new PLGA multiparticulate systems: Microspheres and nanoparticles

    International Journal of Pharmaceutics, Vol. 491, Núm. 1-2, pp. 310-317

  14. Investigating the Discriminatory Power of BCS-Biowaiver in Vitro Methodology to Detect Bioavailability Differences between Immediate Release Products Containing a Class i Drug

    Molecular Pharmaceutics, Vol. 12, Núm. 9, pp. 3167-3174

  15. Mesoporous silicon oxycarbide materials for controlled drug delivery systems

    Chemical Engineering Journal, Vol. 280, pp. 165-174

  16. Novel biodegradable polyesteramide microspheres for controlled drug delivery in Ophthalmology

    Journal of Controlled Release, Vol. 211, pp. 105-117

  17. Novel solid dispersions of benznidazole: Preparation, dissolution profile and biological evaluation as alternative antichagasic drug delivery system

    Experimental Parasitology, Vol. 149, pp. 84-91

  18. Oral particle uptake and organ targeting drives the activity of amphotericin B nanoparticles

    Molecular Pharmaceutics, Vol. 12, Núm. 2, pp. 420-431

  19. Overcoming glucocorticoid resistances and improving antitumor therapies: Lipid and polymers carriers

    Pharmaceutical Research, Vol. 32, Núm. 3, pp. 968-985

  20. Pectin/anhydrous dibasic calcium phosphate matrix tablets for in vitro controlled release of water-soluble drug

    International Journal of Pharmaceutics, Vol. 494, Núm. 1, pp. 235-243